top of page



Biomedical Science

Drug Delivery



Medical Devices


Molecular Biology

Molecular Genetics



Stem Cell Biology

Transgenic Plants and Crops


Gertrud U. Rey, Ph.D.

Patent Agent

Gertrud "Trudy" Rey serves as a patent agent with expertise in the areas of pharmaceuticals and biotechnological arts.  She has strong analytical skills and diverse working knowledge of molecular biology, virology, immunology, biochemistry and genetics.  Dr. Rey has twelve years of scientific research, laboratory, and publication experience.  She is fluent in German, Romanian, and English.


Dr. Rey obtained a Ph.D. in Molecular Genetics and Biochemistry from Georgia State University.  While at GSU, she worked in Dr. Margo Brinton's lab where she analyzed the effects of various cis-acting elements in the West Nile virus genome on viral replication and translation.  Upon finishing her degree, she received a postdoctoral fellowship at the Centers for Disease Control and Prevention where she worked on respiratory syncytial virus vaccine development in mice.  Dr. Rey graduated with a B.S. in Biology from the University of Georgia.

Dr. Rey has presented her research findings at numerous regional and international conferences, such as the Southeastern Regional Virology Conference, the American Society for Virology meeting, and at the Respiratory Syncytial Virus Symposium.  She has also appeared as guest lecturer in several upper level biology courses at Georgia State and Clayton State University.  In addition, Dr. Rey has co-authored several manuscripts including the following:


  • Prophylactic treatment with a G glycoprotein monoclonal antibody reduces pulmonary inflammation in RSV challenged naïve and formalin-inactivated RSV immunized BALB/c mice”, Journal of Virology, 2010, 84:9632-6.

  • Treatment with respiratory syncytial virus G glycoprotein monoclonal antibody or F(ab’)2 components mediates reduced pulmonary inflammation in mice”, Journal of General Virology, 2009, 90:1119-1123

  • Therapeutic monoclonal antibody treatment targeting respiratory syncytial virus G protein mediates virus clearance and reduces RSV pathogenesis in BALB/c mice”, Journal of Infectious Diseases, 2009, 200(3):439-47

  • Effect of Chemokine Receptor CX3CR1 Deficiency in a Murine Model of Respiratory Syncytial Virus Infection”, Comparative Medicine, 2012, 62:14-20

  • Decrease in Formalin-Inactivated Respiratory Syncytial Virus (FI-RSV) Enhanced Disease with RSV G Glycoprotein Peptide Immunization in BALB/c Mice", PLOS ONE, 2013, 8(12):e83075

  • Functional analyses of the three simian hemorrhagic fever virus nonstructural protein 1 papain-like proteases", Journal of Virology, 2014, 88(16):9129-9140


  • Ph.D., Molecular Genetics and Biochemistry, Georgia State University, 2007

  • B.S., Biology, University of Georgia, 1998


Admitted to Practice

  • United States Patent and Trademark Office, 2014


Direct:  478.412.4701 

Please reload

bottom of page